Background: To evaluate the impact of the planning target volume (PTV) density on treatment planning for lung Stereotactic Body Radiation Therapy (SBRT).
Material And Methods: The PTV coverage was analyzed in two groups of 40 lung SBRT patients. One group had PTV density <0.5 g/cm, while the other group had PTV density >0.5 g/cm. The treatments were planned in Pinnacle 9.10, using the collapsed cone convolution (CCC) algorithm. The prescribed dose was 60 Gy to the PTV in 4-8 fractions. Respecting constraint for the PTV coverage (D98% > 95%), we compared changes in the isodose line prescription, the number of monitor units (MU), maximum dose (), irradiated volume covered with 30 Gy (), and the optimization planning volume (OPV).
Results: For the same median values of the PTV coverage (98.3%), the differences are presented with median values between lower and higher density than 0.5 g/cm. The isodose line prescription was 83 90% ( < 0.0001), the MUs were 2294 1655 MU ( < 0.0001), was 74.26 68.09 Gy ( < 0.0001), was 117.03 104.81 cc ( = 0.04), and OPV was 28.48 39.35 cc ( < 0.001). By overriding the ITV density to 0.8 g/cm, the isodose line prescription decreases. The and MUs decrease by 7%, by 34%, and OPV by 70%.
Conclusion: To obtain similar PTV coverage for PTV which is <0.5 g/cm, a larger margin irradiating a large OPV was used. More MUs and a higher maximum dose were delivered. For the PTV density of ≤0.36 g/cm overriding is recommended to reduce the dose and irradiated volume.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/0284186X.2021.1950926 | DOI Listing |
Adv Radiat Oncol
February 2025
Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, Texas.
Purpose: Daily online adaptive radiation therapy (oART) opens the opportunity to treat gastric mucosa-associated lymphoid tissue (MALT) lymphoma with a reduced margin. This study reports our early experience of cone beam computed tomography (CBCT)-based daily oART treating gastric MALT lymphoma with breath-hold and reduced margins.
Methods And Materials: Ten patients were treated on a CBCT-based oART system.
Ann Surg Oncol
January 2025
Section of Plastic and Reconstructive Surgery, Department of Surgery, University of Michigan Health Systems, Ann Arbor, MI, USA.
Background: The placement of breast implants in a prepectoral plane has become increasingly popular in breast reconstruction, although data on how this affects radiation delivery in women with breast cancer are limited. This study aimed to assess the dosimetric differences in radiation plans for immediate breast reconstruction between prepectoral and subpectoral implants.
Methods: In this study, a retrospective review and dosimetric analysis of patients with breast cancer who underwent immediate implant-based reconstruction and postmastectomy radiation therapy (PMRT) were performed.
Strahlenther Onkol
January 2025
Department of Radiation Oncology, Radboud university medical center, Nijmegen, The Netherlands.
Purpose: This study focused on reducing the margin for prostate cancer treatment using magnetic resonance imaging-guided radiotherapy by investigating the intrafractional motion of the prostate and different motion-mitigation strategies.
Methods: We retrospectively analyzed intrafractional prostate motion in 77 patients with low- to intermediate-risk prostate cancer treated with five fractions of 7.25 Gy on a 1.
Clin Oncol (R Coll Radiol)
December 2024
South West Wales Cancer Centre, Swansea, UK; National Radiotherapy Trials Quality Assurance (RTTQA) Group, National Institute for Health and Care Research, UK; Swansea University Medical School, Swansea, UK.
Aims: The SCOPE2 trial evaluates radiotherapy (RT) dose escalation for oesophageal cancer. We report findings from the accompanying RT quality assurance (RTQA) programme and identify recommendations for PROTIEUS, the next UK trial in oesophageal RT.
Maetrials And Methods: SCOPE2's RTQA programme consisted of a pre-accrual and on-trial component.
Clin Transl Radiat Oncol
March 2025
Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Purpose: To use imaging data from stereotactic MR-guided online adaptive radiotherapy (SMART) of ultracentral lung tumors (ULT) for development of a safe non-adaptive approach towards stereotactic body radiotherapy (SBRT) of ULT.
Patients And Methods: Analysis is based on 19 patients with ULT who received SMART (10 × 5.0-5.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!